These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10949332

  • 1. Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics.
    Ahn HC, Yang JH, Lee HB, Rhee YK, Lee YC.
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):784-7. PubMed ID: 10949332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Tuberculosis treatment today].
    Nowak D, Radenbach D, Kirsten D, Magnussen H.
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):404-9. PubMed ID: 1926948
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
    Baldan HM, De Rosa HJ, Brunetti IL, Ximenes VF, Machado RG.
    Biopharm Drug Dispos; 2007 Nov; 28(8):409-13. PubMed ID: 17828712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
    Zítková L, Janků I, Tousek J, Papezová E, Stastná J.
    Czech Med; 1983 Nov; 6(4):202-17. PubMed ID: 6420125
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC, Pavan EM, Giampaglia CM, Ferrazoli L, Aily DC, de Albuquerque DM, Ramos MC.
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [Abstract] [Full Text] [Related]

  • 11. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [Abstract] [Full Text] [Related]

  • 12. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
    Thee S, Detjen A, Quarcoo D, Wahn U, Magdorf K.
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973
    [Abstract] [Full Text] [Related]

  • 13. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.